Lidocaina Cloridrato Intes

Lidocaine Hydrochloride, the active ingredient in Lidocaina Cloridrato Intes, is a local anesthetic presented as a topical ophthalmic solution for ocular use. It provides surface anesthesia for diagnostic and minor surgical procedures on the eye. GNH USA supplies Lidocaina Cloridrato Intes as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lidocaine Hydrochloride is used as a topical ophthalmic anesthetic to temporarily numb the surface of the eye for various procedures. - Corneal anesthesia: enables painless examination or removal of foreign bodies from the cornea. - Intra‑ocular surgery preparation: provides short‑term numbness during cataract or laser procedures. - Diagnostic testing: facilitates comfortable ocular pressure measurements and fluorescein staining. - Minor ocular trauma care: reduces pain during cleaning and dressing of superficial eye injuries.

Lidocaine Hydrochloride may cause local and systemic adverse reactions when applied to the eye.

Common Side Effects: - Burning or stinging sensation upon instillation. - Transient redness or conjunctival hyperemia. - Tearing or increased lacrimation. - Temporary blurred vision. - Mild allergic conjunctivitis. - Sensation of foreign body in the eye.

Serious or Rare Side Effects: - Corneal epithelial defect or ulceration. - Severe allergic reaction, including angioedema or anaphylaxis. - Persistent visual impairment. - Toxic systemic effects if excessive absorption occurs. - Secondary infection of the ocular surface.

When using Lidocaina Cloridrato Intes, consider the following safety measures. - Allergy assessment: avoid use in patients with known hypersensitivity to lidocaine or amide‑type anesthetics. - Corneal disease: use with caution in eyes with existing epithelial defects or keratitis. - Duration of use: limit application to the shortest time necessary; avoid repeated dosing without medical supervision. - Systemic exposure: monitor infants and patients with compromised hepatic function for signs of systemic toxicity. - Interaction with other eye drops: separate administration times to reduce local irritation. - Store at room temperature: keep in the original container, protect from light and moisture.

Lidocaina Cloridrato Intes may interact with other medications applied to the eye or systemically absorbed.

Major Interactions (Avoid): - Concurrent systemic lidocaine therapy: risk of cumulative toxicity. - Other topical ocular anesthetics: additive local anesthetic effect may increase corneal toxicity. - Strong CYP3A4 inhibitors (e.g., ketoconazole): may raise systemic lidocaine levels.

Moderate Interactions (Monitor Closely): - Beta‑blocker eye drops: may potentiate local cardiovascular effects if absorbed. - Antihistamine eye preparations: could alter ocular surface tolerance. - Alcohol‑containing solutions: may increase irritation and systemic absorption.